Shenzhen Neptune Biotechnology Co., Ltd. (SZ000078) (hereinafter referred to as "Neptune Biotechnology") was founded in Shenzhen in 1992 and listed on the Shenzhen Stock Exchange in 1998. It is a large-scale comprehensive pharmaceutical enterprise group with pharmaceutical research and development, pharmaceutical commerce, and pharmaceutical industry as its core businesses. In order to strengthen mutual understanding and in-depth cooperation between the two parties in the field of biopharmaceuticals, and jointly promote the development of the health industry under the guidance of the "Healthy China 2030 Plan", on September 25, 2024, Mr. Zhang Yifei, Secretary of the Party Committee, Director, and Executive Vice President of Neptune Biotechnology, visited Zhejiang GENOM Life Health Holding Group Co., Ltd. (hereinafter referred to as "GENOM BIO") for visits and exchanges.
After Mr. Zhang and his party visited the GENOM Health Operation Center under GENOM BIO, Dr. Li Liang, Chairman and President of GENOM BIO, introduced the group's history, scientific research achievements and future development strategies in detail to the visiting guests. Dr. Li Liang said that GENOM BIO has always adhered to the concept of innovation-driven development, while maintaining its existing advantages, it actively explores new growth points and strives to forge ahead in the ever-changing market environment.
Mr. Zhang and his delegation had in-depth exchanges and discussions with the senior management team of GENOM BIO on GENOM BIO's corporate culture, development strategy, scientific and technological expertise, operation team, biological products and their market potential, and hoped to have further communication and exchanges.
The visit of the leaders of Shenzhen Neptunus Biotechnology not only deepened the mutual understanding and trust between the two parties, but also laid a solid foundation for future in-depth strategic cooperation. Both parties expressed their expectation to contribute to the overall level of my country's biopharmaceutical industry through further cooperation and exchanges.